Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for inhibition of small abdominal aortic aneurysm growth
NL-OMON51630Phase 2Recruiting
- Sponsor
- Uppsala University
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metformin in abdominal aortic aneurysm (AAA) (2 arms), sponsored by Uppsala University. Primary endpoints: Change in AAA diameter on CT and Interim STOP/GO analysis. Started Nov 2022; status: recruiting.
02
Drugs
metformin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NL-OMON51630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51630.